Smoflipid Injection, Emulsion
Product Images NDC 63323-820

25 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Smoflipid (NDC 63323-820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Smofl-img-01.jpg (Smofl Img 01)

Smofl-img-01.jpg (Smofl Img 01)
An instructional diagram showing the assembly or connection of a dual-chamber intravenous infusion bag with two separate ports labeled A and B. The illustration highlights the connectors at the bottom of the bag, depicting how the emulsion components might be mixed or administered.*
FDA Label Image

Smofl-img-02.jpg (Smofl Img 02)

Smofl-img-02.jpg (Smofl Img 02)
An instructional illustration showing two hands pulling apart the sealed ends of a flexible medical bag or pouch, which appears to be a preparation or administration step for an intravenous injection emulsion such as Smoflipid.*
FDA Label Image

Smofl-img-03.jpg (Smofl Img 03)

Smofl-img-03.jpg (Smofl Img 03)
An instructional diagram showing hands holding an ampule and preparing to break its neck. The image likely illustrates the proper method for opening the ampule before use, relevant for intravenous injection products like Smoflipid emulsion.*
FDA Label Image

Smofl-img-04.jpg (Smofl Img 04)

Smofl-img-04.jpg (Smofl Img 04)
An instructional illustration showing a hand inserting or twisting a syringe onto a vial or ampule, demonstrating preparation or connection for intravenous injection use, relevant for Smoflipid intravenous emulsion injection.*
FDA Label Image

Smofl-img-05.jpg (Smofl Img 05)

Smofl-img-05.jpg (Smofl Img 05)
Smoflipid intravenous injection emulsion bag, a human prescription drug by Fresenius Kabi USA, LLC. The image shows a flexible plastic IV bag with connectors at the bottom for intravenous administration, typical of lipid emulsions used for parenteral nutrition. No specific strength or volume is visible on the bag.*
FDA Label Image

Smofl-img-06.jpg (Smofl Img 06)

Smofl-img-06.jpg (Smofl Img 06)
A cumulative incidence function chart comparing Soybean Oil and SMOFlipid intravenous injections over 84 study days. The chart shows the cumulative incidence on the vertical axis and study days on the horizontal axis, with separate curves for Soybean Oil and SMOFlipid, including censored data points. Below the graph, the number of patients at risk for each product is listed across multiple study days, highlighting differences in event occurrence between the two groups.*
FDA Label Image

Smofl-struc-01.jpg (Smofl Struc 01)

Smofl-struc-01.jpg (Smofl Struc 01)
Chemical structure of Smoflipid, showing the molecular arrangement with multiple ester groups and fatty acid chains. The diagram includes groups labeled R1, R2, and R3 attached to glycerol backbone ester bonds.*
FDA Label Image

Figure (Smo00 0006 08)

Figure (Smo00 0006 08)
Chemical structure of Smoflipid, an intravenous injection emulsion. The image depicts the molecular arrangement of the active ingredient typically found in Fresenius Kabi USA, LLC's Smoflipid product.*
FDA Label Image

Figure (Smo00 0006 09)

Figure (Smo00 0006 09)
Chemical structure of Smoflipid, illustrating the molecular formula with components such as carbonyl groups and alkyl chains consistent with an emulsion formulation for intravenous injection by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure (Smo00 0006 10)

Figure (Smo00 0006 10)
Chemical structure diagram of Smoflipid, an intravenous injection emulsion. The diagram shows a complex molecular structure representing the active ingredients in Smoflipid as per the product labeling.*
FDA Label Image

Smofl-struc-02.jpg (Smofl Struc 02)

Smofl-struc-02.jpg (Smofl Struc 02)
Chemical structure of the active ingredient Smoflipid, showing a detailed molecular diagram with carbon chains, double bonds, and functional groups characteristic of an emulsion formulation used in intravenous injection.*
FDA Label Image

Smofl-struc-03.jpg (Smofl Struc 03)

Smofl-struc-03.jpg (Smofl Struc 03)
Chemical structure diagram of Smoflipid, showing its molecular composition with carbon chains and bonds arranged in a complex lipid emulsion structure.*
FDA Label Image

Smofl-struc-04.jpg (Smofl Struc 04)

Smofl-struc-04.jpg (Smofl Struc 04)
Chemical structure of Smoflipid, showing its molecular composition and arrangement as an intravenous injection emulsion product by Fresenius Kabi USA, LLC.*
FDA Label Image

Smofl-struc-05.jpg (Smofl Struc 05)

Smofl-struc-05.jpg (Smofl Struc 05)
Chemical structure diagram showing a fatty acid component molecule, likely part of the active ingredient composition of Smoflipid injection emulsion used intravenously.*
FDA Label Image

Smofl-struc-06.jpg (Smofl Struc 06)

Smofl-struc-06.jpg (Smofl Struc 06)
Chemical structure diagram of the active ingredient in Smoflipid injection, emulsion. The image depicts a linear carbon chain with functional groups, consistent with lipid-based molecules used in intravenous emulsions.*
FDA Label Image

Smofl-struc-07.jpg (Smofl Struc 07)

Smofl-struc-07.jpg (Smofl Struc 07)
Chemical structure of the active ingredient Smoflipid depicted as a complex lipid molecule with multiple carbon chains and functional groups, showing a long hydrocarbon chain with carboxyl and ester groups.*
FDA Label Image

Smofl-struc-08.jpg (Smofl Struc 08)

Smofl-struc-08.jpg (Smofl Struc 08)
Chemical structure diagram of the active ingredient in Smoflipid, an intravenous emulsion injection by Fresenius Kabi USA, LLC. The structure depicts a complex molecular arrangement typical of lipid-based compounds.*
FDA Label Image

Smofl-struc-09.jpg (Smofl Struc 09)

Smofl-struc-09.jpg (Smofl Struc 09)
Chemical structure diagram of the active ingredient Smoflipid, showing a multi-double-bond fatty acid chain with a terminal carboxylic acid group, consistent with an intravenous lipid emulsion formulation.*
FDA Label Image

Smofl-struc-10.jpg (Smofl Struc 10)

Smofl-struc-10.jpg (Smofl Struc 10)
Chemical structure of the active ingredient in Smoflipid injection emulsion, showing a complex lipid molecule with multiple carbon-carbon double bonds and a terminal carboxyl group.*
FDA Label Image

Smofl-logo-01.jpg (Smofl Logo 01)

FDA Label Image

Smofl-label-01.jpg (Smofl Label 01)

Smofl-label-01.jpg (Smofl Label 01)
Smoflipid 20% lipid injectable emulsion, USP, 20 grams/100 mL intravenous injection. Each 100 mL contains 6 g Soybean Oil, 6 g Medium Chain Triglycerides, 5 g Olive Oil, and 3 g Fish Oil. The label includes storage instructions, usage warnings, manufacturer Fresenius Kabi USA, LLC, and NDC 63323-820-01. The product is sterile, single-use, and in a 100 mL container.*
FDA Label Image

Smofl-label-02.jpg (Smofl Label 02)

Smofl-label-02.jpg (Smofl Label 02)
Smoflipid 20% lipid injectable emulsion, USP, 20 grams per 100 mL (0.2 grams/mL) for intravenous use, manufactured by Fresenius Kabi USA, LLC, Uppsala, Sweden. The label lists active ingredients in each 100 mL: soybean oil 6 g, medium chain triglycerides 6 g, olive oil 5 g, fish oil 3 g. Additional components include glycerol, purified egg phospholipids, tocopherol, sodium oleate, and water for injection, with specified osmolarity and aluminum content limits. Storage instructions and usage warnings are provided, along with barcode and lot/expiration placeholders.*
FDA Label Image

Smofl-label-03.jpg (Smofl Label 03)

Smofl-label-03.jpg (Smofl Label 03)
Label of Smoflipid injection, emulsion, USP 20%, 50 grams/250 mL (0.2 grams/mL) for intravenous use. The 250 mL bag contains 6 g soybean oil, 6 g medium chain triglycerides, 5 g olive oil, and 3 g fish oil per 100 mL. Manufactured by Fresenius Kabi USA, LLC, Uppsala, Sweden. Includes storage instructions, usage directions, and safety warnings.*
FDA Label Image

Smofl-label-04.jpg (Smofl Label 04)

Smofl-label-04.jpg (Smofl Label 04)
Smoflipid lipid injectable emulsion, USP, 20%, 100 grams/500 mL intravenous injection label. Contains soybean oil 6 g, medium chain triglycerides 6 g, olive oil 5 g, and fish oil 3 g per 100 mL. Manufactured by Fresenius Kabi USA, LLC, Uppsala, Sweden. Includes usage, storage, and safety information, including energy content, osmolarity, and single-use instructions.*
FDA Label Image

Smofl-label-05.jpg (Smofl Label 05)

Smofl-label-05.jpg (Smofl Label 05)
Smoflipid injection, emulsion 20%, 1000 mL pharmacy bulk package label. Contains 6 g soybean oil, 6 g medium chain triglycerides, and 3 g fish oil per 100 mL. Label states not for direct infusion, for intravenous use only, sterile, store below 25°C, manufactured by Fresenius Kabi USA, LLC, Uppsala, Sweden. Includes warnings about product use and ingredients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.